Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LNN

Lindsay Corp. Adds GE Healthcare CIO to Board

Lindsay Corporation (NYSE: LNN) has announced the appointment of Jahidul H. Khandaker to its board of directors. Mr. Khandaker, who serves as the Chief Information Officer for GE Healthcare, brings over 25 years of experience leading enterprise-wide technology transformations across various industries.

Lindsay's Chairman, Robert Brunner, noted that Mr. Khandaker's extensive experience in technology transformation and operational excellence at world-class companies will add valuable expertise to Lindsay’s board as the company advances its strategic priorities and long-term growth objectives.

Moreover, Lindsay’s President and CEO, Randy Wood, expressed pleasure in welcoming Mr. Khandaker to the board, emphasizing that his deep expertise in technology, operations, and global markets aligns with the company's strategic priorities and will support continued investment in innovation, cybersecurity, and artificial intelligence.

Established in 1955, Lindsay Corporation is a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology. The company's irrigation brands include Zimmatic™ center pivot and lateral move agricultural irrigation systems, FieldNET™ and FieldNET Advisor™ remote irrigation management technology, and industrial IoT solutions. Additionally, Lindsay Transportation Solutions manufactures equipment to improve road safety and keep traffic moving on the world’s roads, bridges, and tunnels through the Road Zipper™ and Snoline™ brands. Today the company's shares have moved 0.21% to a price of $139.81. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS